Veriheal

JANUARY 11, 2023

Not only this, but Gaize recently completed the largest clinical trial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. How do you feel about this being the largest cannabis impairment clinical trial ever?

Clinical Trials 98

Clinical Trials THC Data Safety 98

LifeCannMD

JULY 3, 2024

Medical marijuana contains numerous compounds, but the two most studied are: THC (tetrahydrocannabinol): The psychoactive component responsible for the “high” associated with marijuana. THC, at low doses, can produce a calming effect, but higher doses may increase anxiety in some individuals.

Treatment 96

Treatment Clinical Trials Marijuana Sleep 96

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. The flower contained high levels of THC in the range of 15-25 milligrams, with CBD content resting on the lower end of the spectrum at 0.5

Clinical Trials 116

Clinical Trials Chronic Pain Hydroponic Strains 116

Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The investigational new drug, IGC-AD1, is IGC’s proprietary Tetrahydrocannabinol (THC)-based candidate designed to treat certain symptoms of Alzheimer’s disease.

Clinical Trials 40

Clinical Trials Data Patients THC 40

Project CBD

NOVEMBER 11, 2023

So just on safety alone, it’s worth using it. Some years ago, our government allowed the use of Marinol, which is synthetic THC, especially for cancer patients. We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Cannabis Law Report

JULY 4, 2021

The level of THC in CBD products should fall below 0.2% Also, alone it won’t create the “high” sensation associated with the use of Tetrahydrocannabinol or THC. Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. What is THC? CBD vs THC.

THC 81

THC CBD Legalization Oil 81

The Cannigma

DECEMBER 14, 2021

This synthetic derivative of naturally occurring delta-9-Tetrahydrocannabinol (delta-9-THC) was first reported by noted cannabis chemist Professor Roger Adams at the University of Illinois in 1940. It was also later found that HHC can be produced in the lab during the conversion of THC to CBN in what is known as a disproportionation reaction.

Research and Development 116

Research and Development Clinical Trials Cannabinoids THC 116

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?

DEA 51

DEA Clinical Trials THC Research and Development 51

MMJ Recs

JULY 5, 2024

The use of THC (Tetrahydrocannabinol) has surged dramatically over the years with an increasing interest in the potential health benefits for medical marijuana patients. From pain management to mental health, THC is being explored for its therapeutic properties at an unprecedented rate. What is THC?

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

CannaMD

SEPTEMBER 28, 2020

However, there is a tradeoff between effectiveness and safety. Modern scientists are looking at the effects of both delta-9-tetrahydrocannabinol ( THC ) and cannabidiol ( CBD ) on sleep. Scientists have also studied combinations of THC and CBD, such as Sativex clinical trials that show patients’ marked improvement in sleep.

Sleep 101

Sleep Clinical Trials Patients THC 101

The Cannigma

FEBRUARY 2, 2021

However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. million clinical trial investigating the effects of CBD on hallucinations and delusions related to the disease.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Canna Care Docs

OCTOBER 3, 2023

Alleviating Symptoms with Cannabinoids As more states legalize medical cannabis, many researchers and clinicians are studying the efficacy of cannabinoids like THC and CBD for alleviating these symptoms. This study looked at major cannabinoids such as THC and their accuracy and effectiveness in treating the effects of nausea and vomiting.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

MMJ Recs

JULY 9, 2024

Medical Marijuana: An Overview Medical marijuana refers to the use of cannabis and its cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), for medicinal purposes. THC and CBD have demonstrated anti-inflammatory properties that can help reduce neuroinflammation associated with MS. Image by Jeff W on Unsplash.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels. Westlund, Department of Anesthesiology.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

AUGUST 21, 2019

However, health professionals have been reluctant to prescribe cannabis-based medicines in the UK because of the lack of clinical trial evidence of its benefits and safety. This would answer questions about safety and efficacy, they said. The final guideline is expected to be published in November 2019.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

The Joint Blog

JUNE 2, 2020

According to a new study published in the European Journal of Pain, delivering a precise doses of THC via a specialized inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

Chronic Pain 58

Chronic Pain Clinical Trials Marijuana Safety 58

Cannabis Law Report

JUNE 17, 2021

Brains is one of a few companies in the world producing CBD as an API for pharmaceutical applications, research, development, and clinical trials. CBD and zero Tetrahydrocannabinol (THC). These screening reports have confirmed that Brains’ CBD API is free of THC, pesticides and other banned substances listed by WADA.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Events 105

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

Peninsula Alternative Health

MAY 15, 2019

At this point, it seems seizure disorders respond best to a range of 27:1 to 15:1 CBD: THC full spectrum cannabis oil. tetrahydrocannabinol (THC). Although this experimental approach can be intimidating for many, it is important to note that cannabis has an excellent safety profile and is well tolerated by most.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

MMJ Recs

NOVEMBER 30, 2023

The two most well-known compounds in cannabis are tetrahydrocannabinol (THC) and cannabidiol (CBD), each of which has distinct effects on the human body. THC and Epilepsy Relief Tetrahydrocannabinol (THC), the primary psychoactive compound found in cannabis, has been a subject of interest in the context of epilepsy treatment.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

The Joint Blog

APRIL 17, 2020

According to a new study in the Journal of Clinic Medicine , the use of Tetrahydrocannabinol (THC) could have adverse drug effects when combined with other medications due to drug-drug interactions. Its psychoactive ingredient, THC, has made cannabis a highly used recreational drug for millennia. Cannabis Sativa, a.k.a

Events 48

Events THC Chronic Pain Sleep 48

Veriheal

APRIL 11, 2022

In particular, of all the components contained in the cannabis plant— including cannabinoids , terpenes , and flavonoids — the cannabis compound tetrahydrocannabinol (THC) has proven to harbor medicinal benefits when used in specific formulations. The debate surrounding cannabis’ potentially therapeutic powers has ensued for decades.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

The Cannigma

JULY 1, 2022

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.

Research and Development 108

Research and Development Data THC Clinical Trials 108

TheAnswerPage

NOVEMBER 30, 2021

Psilocybin, the hallucinogen found in “magic mushrooms” has been used in clinical trials. According to the CSA, schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.

Clinical Trials 40

Clinical Trials Safety Treatment THC 40

Cannabis Law Report

JULY 8, 2021

Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest. produced, THC-free 1 CBD products. Sibyl Swift, VP, Scientific & Regulatory Affairs. cbdMD, Inc.

Research and Development 85

Research and Development Pets Cannabinoids eCommerce 85

Project CBD

FEBRUARY 28, 2023

According to the FDA, “hemp” is defined as Cannabis sativa with a tetrahydrocannabinol (THC) concentration of 0.3% THC is the primary psychoactive compound in cannabis.) THC is considered “marijuana” or “cannabis.” Cannabis sativa with more than 0.3% Accessed October 17, 2022. Miller OS, Elder EJ, Jones KJ, Gidal BE.

CBD 144

CBD Seed-To-Sale Food Access 144

LifeCannMD

AUGUST 2, 2024

Cannabinoids like THC and CBD bind to ECS receptors, potentially reducing inflammation and pain perception. THC (Tetrahydrocannabinol) is the psychoactive component of cannabis that helps with pain relief and relaxation. More clinical trials are needed to establish definitive efficacy and safety profiles.

Clinical Trials 52

Clinical Trials Marijuana Research and Development Cannabinoids 52

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary psychoactive compound in cannabis, responsible for the “high” or euphoric feeling associated with marijuana use.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MMJ Recs

DECEMBER 28, 2023

THC, the psychoactive component of cannabis, has analgesic properties that can help manage chronic pain conditions, such as neuropathic pain and arthritis. Strains with a balanced THC and CBD ratio are often recommended for their synergistic effects in pain relief without the intense psychoactive experience.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

SpeedWeed

AUGUST 5, 2021

As a growing number of states step in to regulate these controversial substances, such as delta-8 tetrahydrocannabinol (THC), multiple cannabinoids join the fray. A semi-synthetic cannabinoid known as THC-O acetate is one substance gaining attention. Certainly THC-O acetate falls in that category. Why would someone do this?

THC 52

THC Vaping Cannabinoids Hemp 52

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Thanks to their diligence in perfecting the drug and ensuring its safety for intended use, the Drug Enforcement Agency scheduled Epidiolex under the lowest Schedule classification for controlled substances. Epidiolex contains no THC, the main psychoactive ingredient that produces euphoria from smoking marijuana.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

OCTOBER 20, 2021

s NORML Coordinator Dale Gieringer, Delta-8 has undergone minimal testing in humans, “therefore, little is known about its long-term safety, its consumption at high dosages, or its medicinal effects.” Additionally, the advocacy group views Delta-8 THC as a Schedule I substance under federal law. According to Calif.’s Law 360 (sub.

Hemp 52

Hemp Clinical Trials CBD Legalization 52

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen.

CBD 98

CBD THC Conditions Medicine 98

The Joint Blog

JANUARY 23, 2020

” The systematic review of the literature “was conducted during 2019, assessing the data from all case studies and clinical trials involving medicinal cannabis or plant-derived isolates for all major psychiatric disorders (neurological conditions and pain were omitted).”

Clinical Trials 52

Clinical Trials Marijuana Sleep Cannabinoids 52

MMJ Recs

JULY 11, 2024

In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals.

Sleep 111

Sleep Treatment Research and Development Therapy 111